7Baggers
 Precision Trading with Y-mabs Therapeutics Inc. (YMAB) Risk Zones  news.stocktradersdaily.com Thu, 13 Nov 2025 00:54:01 GMT
 is y mabs therapeutics inc. stock a dividend growth opportunity  newser.com Sun, 09 Nov 2025 20:08:40 GMT
 does y mabs therapeutics inc. stock trade at a discount to peers  newser.com Tue, 28 Oct 2025 10:25:17 GMT

Y-mAbs Therapeutics, Inc
(NASDAQ:YMAB) 

YMAB stock logo

Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophag...

Founded: 2015
Full Time Employees: 65
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends